by Eric Christianson | Jun 18, 2025 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Rheumatoid arthritis (RA) often requires complex, long-term medication regimens. This polypharmacy increases the risk of clinically significant drug interactions that can impact efficacy and safety. Below are five of the most important drug interactions encountered in...
by Eric Christianson | Apr 10, 2024 | Dermatology, ENT, Ophthalmology Medication and Disease State Clinical Pearls, Infectious Disease and Oncology Medication and Disease State Clinical Pearls, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
I was recently asked about the use of vaccines and adalimumab (Humira). More specifically, can we give vaccines if the patient is taking a biologic agent like adalimumab? It isn’t a simple yes or no answer as it depends upon the type of vaccine. More...
by Eric Christianson | Nov 15, 2013 | Personal Stories From The Front Lines of Clinical Pharmacy
I just wanted to cover a question that I get asked from time to time. My real world thoughts on vaccines: It certainly is a controversial topic and people have seriously strong opinions about this issue, so I approach it with that in mind. I personally see the impact...
